Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15 - Image 1

£109.85

Springer Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15

Name: Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15
Brand: Springer
Price: 111.97 GBP
Availability: InStock

Oncology

New to our records — first sighting 18 days ago. We'll learn its rhythm.

18 days of data · current price £110

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days • 18 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 18 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £110 (11 days, 61.1%)

Price range: £110 - £112

Price levels: 2 different prices over 18 days

Description

Product Description This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. From the Back Cover This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. About the Author Yosef Yarden, PhD, is Professor, Department of Biological Regulation, The Weizmann Institute of Science, Israel.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3030098176
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 02 February 2019
Listed Since: 02 February 2019

Barcode

No barcode data available

Springer Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15

New to our records — first sighting 18 days ago. We'll learn its rhythm.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Gene Regulation and Therapeutics for Cancer

Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)

Cell Signaling & Molecular Targets in Cancer

Systems Biology in Cancer Research and Drug Discovery

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Cancer Drug Discovery: Science and History

Molecular Targets and Strategies in Cancer Prevention

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

The Hippo Signaling Pathway and Cancer

Nutraceuticals and Cancer

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Targeting the Wnt Pathway in Cancer

Pathobiology of Cancer Regimen-Related Toxicities

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Molecular Pathogenesis of Colorectal Cancer

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Protein Tyrosine Phosphatases in Cancer